With US tar­iffs on phar­ma­ceu­ti­cals like­ly to come “ very soon ,” an­oth­er of the world’s largest drug­mak­ers is ...

RFK Jr.'s first TV interview as HHS head reveals vaccine skepticism, support for measles shots, Novavax concerns, HHS cuts, ...

Trump signals imminent pharma tariffs, with experts including Mollie Sitkowski of Faegre Drinker suggesting 25% levy possible ...

VC execs write to Sen. Cassidy about FDA staffing concerns, citing delays & uncertainties due to loss of experienced staff & ...

Researchers at AAN meeting discuss myasthenia gravis advances as J&J reports long-term data for nipocalimab, while argenx's ...

For years, investors have poured billions into mental health startups, making it the top-funded area in digital health. But ...

A biotech incubated by RA Capital has secured a $57.5 million Series B to begin a mid-stage trial for its cardio drug this ...

Tempest Therapeutics is mulling its business options, including potential exit pathways, after an inability to raise cash to ...

Study shows Dartmouth's Therabot AI chatbot reduced anxiety, depression symptoms in 210-person trial, with users reporting ...

DHL Group investing €2B in healthcare/life sciences, AGC Biologics adds bioreactors in Japan, OXB reports revenue growth, ...

Alzheon's valiltramiprosate (ALZ-801) fails Phase 3 trial in Alzheimer's patients with APOE4 gene copies, showing no significant cognitive decline slowdown despite safer profile than competitors.

HHS and 19 other government agencies can follow through with firing thousands of probationary workers after a federal appeals ...